LTC1781789I2 - Timidinkinazė - Google Patents

Timidinkinazė

Info

Publication number: LTC1781789I2
Authority: LT; Lithuania
Prior art keywords: kinase; timidin; nucleotides; splice; polynucleotide
Prior art date: 2004-06-18

Application number

LTPA2016047C

Other languages

English (en)

Original Assignee

Molmed Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-18

Filing date

2016-12-28

Publication date

2018-10-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32750189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTC1781789(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-12-28 Application filed by Molmed Spa filed Critical Molmed Spa

2017-01-25 Publication of LTPA2016047I1 publication Critical patent/LTPA2016047I1/lt

2018-10-10 Publication of LTC1781789I2 publication Critical patent/LTC1781789I2/lt

Links

108091000080 Phosphotransferase Proteins 0.000 title 1
102000020233 phosphotransferase Human genes 0.000 title 1
239000002773 nucleotide Substances 0.000 abstract 5
125000003729 nucleotide group Chemical group 0.000 abstract 5
108020005067 RNA Splice Sites Proteins 0.000 abstract 2
102000006601 Thymidine Kinase Human genes 0.000 abstract 1
108020004440 Thymidine kinase Proteins 0.000 abstract 1
108091033319 polynucleotide Proteins 0.000 abstract 1
239000002157 polynucleotide Substances 0.000 abstract 1
102000040430 polynucleotide Human genes 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C12N9/1211—Thymidine kinase (2.7.1.21)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Oncology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)

LTPA2016047C 2004-06-18 2016-12-28 Timidinkinazė LTC1781789I2 (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0413702.2A GB0413702D0 (en)	2004-06-18	2004-06-18	Thymidine kinase
PCT/IB2005/002358 WO2005123912A2 (en)	2004-06-18	2005-06-17	Thymidine kinase

Publications (2)

Publication Number	Publication Date
LTPA2016047I1 LTPA2016047I1 (lt)	2017-01-25
LTC1781789I2 true LTC1781789I2 (lt)	2018-10-10

Family

ID=32750189

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTPA2016047C LTC1781789I2 (lt)	2004-06-18	2016-12-28	Timidinkinazė

Country Status (20)

Country	Link
US (5)	US8357788B2 (lt)
EP (1)	EP1781789B1 (lt)
JP (1)	JP5091669B2 (lt)
KR (1)	KR101337210B1 (lt)
CN (1)	CN101010428B (lt)
AT (1)	ATE520779T1 (lt)
AU (1)	AU2005254807B2 (lt)
CA (1)	CA2569304C (lt)
CY (2)	CY1111925T1 (lt)
DK (1)	DK1781789T3 (lt)
ES (1)	ES2372022T3 (lt)
GB (1)	GB0413702D0 (lt)
HU (1)	HUS1600064I1 (lt)
IL (2)	IL179660A (lt)
LT (1)	LTC1781789I2 (lt)
NL (1)	NL300856I2 (lt)
PL (1)	PL1781789T3 (lt)
PT (1)	PT1781789E (lt)
SI (1)	SI1781789T1 (lt)
WO (1)	WO2005123912A2 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0413702D0 (en)	2004-06-18	2004-07-21	Molmed Spa	Thymidine kinase
CN103842501B (zh)	2011-10-05	2017-12-08	莫尔梅德股份有限公司	病毒载体纯化系统
KR102077648B1 (ko) *	2017-12-28	2020-02-14	주식회사 바이오녹스	안전성 및 항암효과가 개선된 종양 용해 바이러스
US11157042B1 (en)	2018-03-28	2021-10-26	Douglas Patton	Systems and methods for interaction of wearable communication devices
EP3802796A1 (en)	2018-05-30	2021-04-14	Glycostem Therapeutics B.V.	Car nk cells
AU2020306544B2 (en) *	2019-06-27	2025-10-16	Bionoxx Inc.	Oncolytic virus with improved safety and anticancer effects
WO2025168661A1 (en)	2024-02-05	2025-08-14	Ospedale San Raffaele S.R.L.	Chimeric antigen receptor

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990007936A1 (en)	1989-01-23	1990-07-26	Chiron Corporation	Recombinant therapies for infection and hyperproliferative disorders
DE69032841T2 (de)	1989-01-23	1999-05-12	Chiron Corp., Emeryville, Calif.	Rekombinante zellen für therapien von infektionen und hyperprolieferative störungen und deren herstellung
US5631236A (en)	1993-08-26	1997-05-20	Baylor College Of Medicine	Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
IT1261847B (it)	1993-09-01	1996-06-03	San Romanello Centro Fond	Metodo per marcare cellule eucariote.
FR2712603B1 (fr)	1993-11-18	1996-02-09	Centre Nat Rech Scient	Virus recombinants, préparation et utilisation en thérapie génique.
ATE211174T1 (de)	1994-05-02	2002-01-15	Univ Washington	Thymidin-kinase-mutanten
FR2744731B1 (fr)	1996-02-09	1998-05-22	Rhone Poulenc Rorer Sa	Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
FR2751988B1 (fr)	1996-08-01	1998-09-11	Rhone Poulenc Rorer Sa	Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
WO1997029196A1 (fr)	1996-02-09	1997-08-14	Rhone-Poulenc Rorer S.A.	Variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
AU726584B2 (en)	1996-04-10	2000-11-09	University Of Southern California	Gene therapy for proliferative vitreoretinopathy
EP2298350A3 (en)	1996-07-26	2011-06-08	Susan P. Perrine	Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders
EP2386630A1 (en)	1997-10-14	2011-11-16	Darwin Molecular Corporation	Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
GB0008966D0 (en) *	2000-04-13	2000-05-31	Imp College Innovations Ltd	Vectors for gene therapy
CN1273587C (zh) *	2002-06-05	2006-09-06	上海新世界基因技术开发有限公司	疱疹病毒胸苷激酶突变体及其应用
DE50213745D1 (de)	2002-12-09	2009-09-17	Celltech Gmbh Biotechnologie	Verbesserte retrovirale Vektoren für die Gentherapie
GB0413702D0 (en)	2004-06-18	2004-07-21	Molmed Spa	Thymidine kinase

2004
- 2004-06-18 GB GBGB0413702.2A patent/GB0413702D0/en not_active Ceased
2005
- 2005-06-17 WO PCT/IB2005/002358 patent/WO2005123912A2/en not_active Ceased
- 2005-06-17 PT PT05766582T patent/PT1781789E/pt unknown
- 2005-06-17 EP EP05766582A patent/EP1781789B1/en not_active Expired - Lifetime
- 2005-06-17 ES ES05766582T patent/ES2372022T3/es not_active Expired - Lifetime
- 2005-06-17 JP JP2007516075A patent/JP5091669B2/ja not_active Expired - Fee Related
- 2005-06-17 US US11/629,962 patent/US8357788B2/en not_active Expired - Fee Related
- 2005-06-17 SI SI200531385T patent/SI1781789T1/sl unknown
- 2005-06-17 PL PL05766582T patent/PL1781789T3/pl unknown
- 2005-06-17 CN CN2005800286686A patent/CN101010428B/zh not_active Expired - Fee Related
- 2005-06-17 DK DK05766582.0T patent/DK1781789T3/da active
- 2005-06-17 CA CA2569304A patent/CA2569304C/en not_active Expired - Fee Related
- 2005-06-17 AU AU2005254807A patent/AU2005254807B2/en not_active Ceased
- 2005-06-17 KR KR1020077001055A patent/KR101337210B1/ko not_active Expired - Fee Related
- 2005-06-17 AT AT05766582T patent/ATE520779T1/de active
2006
- 2006-11-28 IL IL179660A patent/IL179660A/en active IP Right Grant
2011
- 2011-05-24 IL IL213084A patent/IL213084A0/en unknown
- 2011-10-10 CY CY20111100964T patent/CY1111925T1/el unknown
2012
- 2012-08-31 US US13/601,174 patent/US8642311B2/en not_active Expired - Fee Related
2013
- 2013-12-10 US US14/101,704 patent/US9005945B2/en not_active Expired - Fee Related
2015
- 2015-04-01 US US14/676,696 patent/US10155052B2/en not_active Expired - Fee Related
2016
- 2016-12-28 CY CY2016054C patent/CY2016054I1/el unknown
- 2016-12-28 LT LTPA2016047C patent/LTC1781789I2/lt unknown
- 2016-12-29 NL NL300856C patent/NL300856I2/nl unknown
- 2016-12-30 HU HUS1600064C patent/HUS1600064I1/hu unknown
2018
- 2018-11-15 US US16/192,224 patent/US10314925B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL213084A0 (en)	2011-07-31
WO2005123912A3 (en)	2006-05-04
CN101010428B (zh)	2013-10-02
WO2005123912A2 (en)	2005-12-29
GB0413702D0 (en)	2004-07-21
US9005945B2 (en)	2015-04-14
PT1781789E (pt)	2011-10-20
US20150231275A1 (en)	2015-08-20
SI1781789T1 (sl)	2012-03-30
US10155052B2 (en)	2018-12-18
PL1781789T3 (pl)	2011-12-30
HUS1600064I1 (hu)	2017-02-28
KR20070032786A (ko)	2007-03-22
US8642311B2 (en)	2014-02-04
HK1097881A1 (en)	2007-07-06
US20130028876A1 (en)	2013-01-31
CA2569304C (en)	2014-08-12
CY2016054I2 (el)	2017-07-12
CA2569304A1 (en)	2005-12-29
US20090130069A1 (en)	2009-05-21
ATE520779T1 (de)	2011-09-15
EP1781789B1 (en)	2011-08-17
IL179660A0 (en)	2007-05-15
KR101337210B1 (ko)	2013-12-06
JP5091669B2 (ja)	2012-12-05
NL300856I2 (lt)	2017-04-20
US8357788B2 (en)	2013-01-22
CY1111925T1 (el)	2015-11-04
LTPA2016047I1 (lt)	2017-01-25
IL179660A (en)	2012-12-31
US10314925B2 (en)	2019-06-11
EP1781789A2 (en)	2007-05-09
CY2016054I1 (el)	2017-07-12
AU2005254807A1 (en)	2005-12-29
JP2008502342A (ja)	2008-01-31
US20190070312A1 (en)	2019-03-07
ES2372022T3 (es)	2012-01-13
AU2005254807B2 (en)	2011-08-18
DK1781789T3 (da)	2011-11-28
CN101010428A (zh)	2007-08-01
US20140178345A1 (en)	2014-06-26

Publication	Publication Date	Title
LTC1781789I2 (lt)	2018-10-10	Timidinkinazė
DE602006015405D1 (de)	2010-08-26	Inkrementelle Assoziation von Metadaten zu Produktionsdaten
ATE430589T1 (de)	2009-05-15	Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
DE602005020229D1 (de)	2010-05-12	Schaufel mit prallgekühltem Übergang von grossem Krümmungsradius
ATE538127T1 (de)	2012-01-15	6-disubstituierte bicyclische nukleinsäureanaloga
ATE500250T1 (de)	2011-03-15	Azetidinverbindungen als orexin-rezeptor- antagonisten
BRPI0510777A (pt)	2007-11-20	indazóis substituìdos, composições que os contêm, processo de produção e utilização
AR047917A1 (es)	2006-03-01	Derivados de 4-benzimidazol-2-il-piridazin-3-ona, preparacion de los mismos, y su empleo en medicamentos
DE602007003410D1 (de)	2010-01-07	Datenschutzgerechte Verknüpfung von Zeichenfolgen
ATE315585T1 (de)	2006-02-15	Multispezifisches reagenz zur selektiven stimulierung von zelloberflächenrezeptoren
DE502004009010D1 (de)	2009-04-02	Prozessor mit verschiedenartigen steuerwerken für gemeinsam genutzte ressourcen
FR2897069B1 (fr)	2012-06-08	Construction de nouveaux variants de l'enzyme dextrane-saccharase dsr-s par ingienerie moleculaire.
ATE487245T1 (de)	2010-11-15	Rehydrierung von brennstoffzellen
NO20100724L (no)	2010-05-28	Ledende sementformulering og anvendelse av denne i en bronn
CR8385A (es)	2006-10-04	Pirimidinas sustituidas con sulfoximina como inhibidores de cdk y/o vegf, su preparacion y sus usos como medicamento
FI20041419L (fi)	2006-05-05	Soodakattilan keon hallinta
MXPA05007538A (es)	2005-09-21	Gen resistente a aphis gossypii.
ITPI20050020A1 (it)	2005-05-24	Calorimetri multimodo a basso costo (cmbc)
ATE497991T1 (de)	2011-02-15	Phosphitester enthaltende stabilisatorzusammensetzung
ATE544599T1 (de)	2012-02-15	Fluidzufuhrsystem
ATE361081T1 (de)	2007-05-15	Verwendung von 5-substituierten nukleosiden zur verstärkung der apoptotischen wirkung von zytostatika
FR2853906B1 (fr)	2006-04-14	N-desoxyribosyltransferases de lactobacilles, sequences nucleotidiques correspondantes et leurs applications
BRPI0815000A2 (pt)	2015-10-27	corante 1,3-tiazolila, seu preparo e uso
ATE443929T1 (de)	2009-10-15	Enzymatische brennstoffzelle
Mori	2007	Engineering Education